Understanding anti‐TNF treatment failure: does serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predict therapeutic outcome to anti‐TNF therapies in biologic‐naïve patients with active luminal Crohn's disease?
Saved in:
| Title: | Understanding anti‐TNF treatment failure: does serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predict therapeutic outcome to anti‐TNF therapies in biologic‐naïve patients with active luminal Crohn's disease? |
|---|---|
| Authors: | Lin, Simeng1,2 (AUTHOR), Chanchlani, Neil1,2 (AUTHOR), Carbery, Isabel3,4 (AUTHOR), Janjua, Malik1,2 (AUTHOR), Nice, Rachel5 (AUTHOR), McDonald, Timothy J.5 (AUTHOR), Bewshea, Claire2 (AUTHOR), Kennedy, Nicholas A.1,2 (AUTHOR), Ahmad, Tariq1,2 (AUTHOR), Selinger, Christian P.3,4 (AUTHOR), Goodhand, James R.1,2 (AUTHOR) james.goodhand@nhs.net |
| Source: | Alimentary Pharmacology & Therapeutics. Sep2022, Vol. 56 Issue 5, p783-793. 11p. 1 Diagram, 3 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 02692813 |
|---|---|
| DOI: | 10.1111/apt.17089 |
